Shuaizhijia Group has launched an upgrade of its European pharmaceutical partnership platform, using Vanke Sky City in Changping District, Beijing as its domestic collaboration hub while improving workflows for product evaluation, registration planning, commercialization strategy and supply chain coordination.
The upgraded platform will deliver full lifecycle digital project management — from first contact and product assessment through registration progress and commercial execution — with clear status tracking and accountability at every node. Core module launch is planned for Q3 2026.
The initiative will help more European pharma companies understand China's regulatory landscape more efficiently and build transparent, traceable long-term collaboration with local partners.
Future updates will continue to focus on compliance, quality and cross-border coordination as key milestones progress.